Relationship between Na(+),K(+)-ATPase and cell attachment.
A prolonged ouabain blockade of the Na(+),K(+)-ATPase detaches cells from each other and from the substrate. This suggests the existence of a link between pump (P) and attachment (A). In the present work, we report that MDCK-W cells treated with ouabain increase tyrosine phosphorylation and content of active MAP kinase, redistribute molecules involved in cell attachment (occludin, ZO-1, desmoplakin, cytokeratin, alpha-actinin, vinculin and actin), and detach. Genistein and UO126, inhibitors of protein tyrosine kinase and of MAP kinase kinase, respectively, block this detachment. The content of P190(Rho-GAP), a GTPase activating protein of the Rho small G-protein subfamily, is increased by ouabain, suggesting that both the Rho/Rac and MAPK pathways are involved. Another clone of MDCK cells whose Na(+),K(+)-ATPase has a negligible affinity for the drug, show none of the effects described for MDCK-W and remain attached. Ma104 cells, a line that has a high affinity for ouabain and stops pumping, fail to modify phosphorylation, as well as the pattern of distribution of attaching molecules, and remain in the monolayer. Taken together, these results suggest that there is a mechanism (P-->A) that transduces a blockade of the pump in a detachment of the cell from neighbors and substrate, in which Ma104 cells are faulty.
Contreras
R G
RG
Center for Research and Advanced Studies of México (CINVESTAV), Av. Instituto Politecnico Nacional 2508, Codigo Postal, 07660 Mexico.
Shoshani
L
L
Flores-Maldonado
C
C
Lázaro
A
A
Cereijido
M
M
D000185:Actinin / Q000378:metabolism; D000199:Actins / Q000378:metabolism; D000818:Animals; D017209:Apoptosis; D002448:Cell Adhesion / Q000187:drug effects / Q000502:physiology*; D015815:Cell Adhesion Molecules / Q000378:metabolism; D002460:Cell Line; D003598:Cytoskeletal Proteins / Q000378:metabolism; D051180:Desmoplakins; D004285:Dogs; D020690:GTPase-Activating Proteins / Q000378:metabolism; D015759:Ionomycin / Q000494:pharmacology; D007633:Keratins / Q000378:metabolism; D007668:Kidney; D007700:Kinetics; D008565:Membrane Proteins / Q000378:metabolism; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D062793:Occludin; D010042:Ouabain / Q000494:pharmacology*; D010750:Phosphoproteins / Q000378:metabolism; D019000:Phosphotyrosine / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D016596:Vinculin / Q000378:metabolism; D062826:Zonula Occludens-1 Protein
D000199:Actins; D015815:Cell Adhesion Molecules; D003598:Cytoskeletal Proteins; D051180:Desmoplakins; D020690:GTPase-Activating Proteins; D008565:Membrane Proteins; D062793:Occludin; D010750:Phosphoproteins; D062826:Zonula Occludens-1 Protein; C085379:rho GTPase-activating protein; D000185:Actinin; D016596:Vinculin; D019000:Phosphotyrosine; D015759:Ionomycin; D010042:Ouabain; D007633:Keratins; D020928:Mitogen-Activated Protein Kinases; D000254:Sodium-Potassium-Exchanging ATPase